Do you want to link to our other external sites and leave Amgen.ca?
You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.
You are now leaving the Amgen.ca website.
The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk
Amgen’s mission is to serve patients, and through continued improvement and specialized technology, we reliably and expertly turn molecules into medicines that reach millions of patients around the world. Our industry-leading manufacturing capabilities combined with our process development expertise, expands what is possible in the fight for patients.
Our unique Amgen methodology marries unconventional thinking with data-driven analysis to deliver therapies of increasing sophistication. This includes a growing number of new drug delivery devices designed to enhance the experience of patients who use our medicines.
Amgen has established a long history of successfully inventing industry-leading technologies and investing in innovation to develop and manufacture biologic medicines for patients with serious illnesses.
At Amgen, we all rally to our common purpose of serving every patient, every time. This commitment requires us to innovate – to rethink how we manufacture, package and deliver products that reach patients when needed, and perform as needed. At every stage of the manufacturing process, we develop and implement innovative technologies to maximize efficiency, quality, safety, and sustainability in service of our mission.
Continuous Improvement is at the heart of everything we do. Every dollar and hour saved, can be used to advance our pipeline, improve - even further - our industry leading manufacturing, and enable us to supply our patients today, and more tomorrow.
We have developed an approach to operations that ensures consistent supply and high-quality consisting of five key areas:
Process development brings a promising molecule from research to clinical trials and beyond. Process development designs the manufacturing process for the small-scale production needed for clinical trials, the commercial-scale process needed to serve a larger population, and the technology required to make the drug in different facilities around the world.
Our manufacturing teams are responsible for making our drugs, first for clinical trials and then, if we receive regulatory approval, on a commercial scale. The manufacturing process varies for each product.
Our colleagues working in the supply chain teams ensure that we have the supply of quality raw materials needed to make our drugs—everything from chemicals and supplies to vials, devices, and packaging materials.
Amgen builds in quality, beginning with the design of medicines, all the way through to their development, manufacturing, and distribution to patients. We include more than 250 quality checks and perform in-depth analysis of our manufacturing performance to continuously improve it.
Our engineering team is responsible for managing the life cycle of Amgen’s physical assets, such as buildings, equipment, utilities, and instruments. They work to continuously to improve these resources so we can better serve our patients.
We have been at the forefront of the medical biotechnology revolution that started in the 1980s, helping invent the processes, methods and technologies that built the global biotechnology industry.